DRUG METABOLISM, ALTERED, CYP2C8-RELATED
|
disease |
|
Disease or Syndrome
|
1
|
1
|
0.400 |
None |
1.000 |
2 |
1
|
2015 |
2016 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.340 |
None |
1.000 |
5 |
|
2017 |
2020 |
Peripheral Nervous System Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
549
|
69
|
0.320 |
None |
1.000 |
2 |
|
2014 |
2016 |
Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1180
|
140
|
0.310 |
None |
1.000 |
1 |
|
2008 |
2008 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1096
|
261
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
L2 Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
53
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Rhabdomyolysis
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
36
|
15
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Rhabdomyolysis, Cerivastatin-Induced
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Arthritis, Gouty
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
206
|
2356
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Bone necrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Pathologic Function
|
23
|
5
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
CUI: |
C0018099 |
Disease: |
Gout
|
Gout
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
205
|
2354
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Hormone measurement
|
group |
|
Laboratory Procedure
|
51
|
134
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Cytokine Measurement
|
phenotype |
|
Laboratory Procedure
|
82
|
123
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.060 |
None |
0.833 |
6 |
1
|
2003 |
2015 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.060 |
None |
1.000 |
6 |
|
2005 |
2018 |